.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Covington
Boehringer Ingelheim
Novartis
AstraZeneca
Argus Health
McKinsey
Medtronic
US Department of Justice
Daiichi Sankyo

Generated: September 25, 2017

DrugPatentWatch Database Preview

COZAAR Drug Profile

« Back to Dashboard

Which patents cover Cozaar, and when can generic versions of Cozaar launch?

Cozaar is a drug marketed by Merck Sharp Dohme and is included in one NDA.

The generic ingredient in COZAAR is losartan potassium. There are thirty-seven drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the losartan potassium profile page.

Summary for Tradename: COZAAR

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list137
Clinical Trials: see list51
Patent Applications: see list4,200
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COZAAR at DailyMed

Pharmacology for Tradename: COZAAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-001Apr 14, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-002Apr 14, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-003Oct 13, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Novartis
Argus Health
Mallinckrodt
Cipla
Moodys
AstraZeneca
Medtronic
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot